胃肠道药理活性素在肝脏健康和疾病中的作用
Matthew Hamang1, Benjamin Yaden1, Guoli Dai1
1Department of Biology, School of Science, Indiana University - Purdue University Indianapolis, IN, United States.
Biochemical pharmacology
|June 26, 2023
概括
活性素调节肝功能,它们的失调与肝脏疾病有关. 抑制活性素显示出治疗肝硬化和癌症等肝病的治疗潜力.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 活性蛋白是TGFβ超级家族成员,调节细胞生长和分化.
- 规范性活性蛋白信号传输涉及Smad2/3,Smad6/7.7的负面反.
- 其他抑制剂包括抑制剂,BAMBI,Cripto,follistatin和fstl3.3.
研究的目的:
- 探索活性素在肝脏生物学中的作用.
- 调查激素失调与肝脏疾病之间的联系.
- 评估活性素作为肝脏疾病的治疗点.
主要方法:
- 关于活性素信号通路的文献综述.
- 分析数据,将活性因失调与肝脏疾病联系起来.
- 检查肝病模型中活性因抑制的研究.
主要成果:
- 活性蛋白A调节肝细胞的增殖,亡,ECM的产生和肝脏的再生.
- 激素失调与肝炎,纤维化和肝细胞癌有关.
- 抑制活性素在肝病的小鼠模型中显示出保护性和再生性作用.
结论:
- 活性素是肝脏生理学的关键调节剂.
- 失调的活性蛋白信号传递有助于各种肝脏疾病.
- 向活性素为肝硬化,纳氏血型肝炎,NAFLD和HCC等肝脏疾病提供了治疗潜力.
相关概念视频
Liver Physiology
679
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
679
Liver Regeneration
3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
Inflammatory Bowel Disease IV: Pharmacological Management
155
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
155
Factors Influencing Drug Absorption: Disease States and Pharmacology
593
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
593
Diseases of the Liver and Gallbladder
674
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
674
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
64
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
64


